Amplia Therapeutics Limited (INNMF)
INNMF Stock Price Chart
Explore Amplia Therapeutics Limited interactive price chart. Choose custom timeframes to analyze INNMF price movements and trends.
INNMF Company Profile
Discover essential business fundamentals and corporate details for Amplia Therapeutics Limited (INNMF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Jan 2021
Employees
—
Website
https://www.ampliatx.comCEO
Christopher J. Burns BSc(Hons),
Description
Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for cancer and fibrotic disease indication. It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
INNMF Financial Timeline
Browse a chronological timeline of Amplia Therapeutics Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 May 2026
Upcoming earnings on 25 Nov 2025
Earnings released on 30 May 2025
Earnings released on 20 Nov 2024
Earnings released on 23 Aug 2024
Earnings released on 30 May 2024
EPS came in at -$0.01 .
Stock split effective on 23 Apr 2024
Shares were split 257 : 250 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Jan 2024
Earnings released on 29 Sept 2023
EPS came in at -$0.00 , while revenue for the quarter reached $783.41K .
Earnings released on 30 Jun 2023
EPS came in at -$0.00 , while revenue for the quarter reached $812.99K .
Earnings released on 31 Mar 2023
EPS came in at -$0.01 , while revenue for the quarter reached -$194.70K .
Earnings released on 31 Dec 2022
EPS came in at -$0.01 , while revenue for the quarter reached -$198.15K .
Earnings released on 29 Sept 2022
EPS came in at -$0.01 , while revenue for the quarter reached $573.30K .
Earnings released on 30 Jun 2022
EPS came in at -$0.01 , while revenue for the quarter reached $608.28K .
Earnings released on 31 Mar 2022
EPS came in at -$0.01 .
Earnings released on 29 Sept 2021
EPS came in at -$0.01 .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 .
Earnings released on 29 Sept 2020
EPS came in at -$0.00 .
INNMF Stock Performance
Access detailed INNMF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.